In 2025, over 200,000 Americans were diagnosed with skin cancer. Thankfully, five months ago, U.S. Dermatology Partners ...

Dermatologists reveal the silent signs of skin cancer that are often overlooked, such as a pimple that doesn't go away. The ...

Abstract: Lung cancer continues to be the leading cause of cancer-related deaths worldwide, and early detection is essential to extending patient life expectancy. The goal of this study is to boost ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Breast cancer remains a significant global health concern, with early detection being crucial for survival. Understanding ...

A groundbreaking study shows that breast cancer screening works better when it’s personalized. Instead of annual mammograms ...

A pioneering study has found that an individualized approach to breast cancer screening that assesses patients' risk, rather than annual mammograms, can lower the chance of more advanced cancers, ...

Abstract: Lymph node metastasis is an important decision-making basis for lung cancer staging and clinical treatment, and will also significantly affect the prognosis of patients. At present, there is ...

Stage 3 colorectal cancer patients with MRD benefit from Celebrex addition to chemotherapy, showing a 40% risk reduction in death for Signatera-positive patients. Celebrex improved disease-free and ...

Researchers at the University of Houston are pushing the boundaries of biomedical innovation with a discovery that could transform treatment for one of cancer’s most devastating complications. In a ...

FDA expands labels for Roche's PATHWAY HER2 (4B5) test* and VENTANA HER2 Dual ISH DNA Probe Cocktail, which can now be used to identify HER2-positive metastatic breast cancer patients that could be ...